Edwards Lifesciences Corporation filed its 10-K Item 1C disclosing its cybersecurity risk management program. The filing states that no known cybersecurity threats have materially affected the company's business or financial condition. It details governance structures, including Board and Audit Committee oversight, and describes security policies, training, and third-party risk management.